Institute of Molecular Genetics of the Czech Academy of Sciences
The world’s largest non-profit dedicated to life science research reagents Ximbio, part of Cancer Research UK’s Commercial Partnerships team, has partnered with IMG.
The world’s largest non-profit dedicated to life science research reagents Ximbio, part of Cancer Research UK’s Commercial Partnerships team, has partnered with IMG. This partnership will make antibodies and other research tools, developed at the Institute of Molecular Genetics of the Czech Academy of Sciences, available to researchers worldwide.
“Recent events have shown the importance of increasing access to resources that accelerate life science research. We are delighted to partner with Ximbio to make not only our antibodies available worldwide” said Pavel Dráber.
Michal Schmoranz, M.Sc.,
phone: (+420) 296 443 199, e-mail: michal.schmoranz@img.cas.cz,
web: www.img.cas.cz/results/technology-transfer/
More information – https://ximbio.com.